To overcome this issue, we decided to assess the chemokine production (CCL2, CCL4, CCL5, CX3CL1 and CXCL10) in a human BBB model with PBMCs obtained from three groups of patients as follow: controls, mild AD and moderated AD patients. This evidence concerns the gene CCL2 and Alzheimer disease.